Cardiol Therapeutics (CRDL) Accounts Payables (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Accounts Payables came in at $2.5 million in Q1 2026, down 53.63% YoY from $5.4 million in Q1 2025, and little changed on a QoQ basis from $2.5 million in Q4 2025.
Cardiol Therapeutics (CRDL) Accounts Payables (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Accounts Payables data on file, last reported at $2.5 million in Q1 2026.
- Quarterly Accounts Payables fell 53.63% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 53.63% YoY) and the FY2025 annual result came in at $2.5 million, down 50.05% from the prior year.
- Accounts Payables held at $2.5 million in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $6.9 million in Q2 2024 to a low of $2.4 million in Q3 2025.
- A 5-year average of $5.1 million and a median of $5.4 million in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables jumped 193.3% — and 2026, when it sank 53.63%.
- Tracing CRDL's Accounts Payables over 5 years: stood at $6.9 million in 2022, then dropped by 14.1% to $5.9 million in 2023, then decreased by 15.45% to $5.0 million in 2024, then plunged by 50.05% to $2.5 million in 2025, then retreated by 0.04% to $2.5 million in 2026.
- The last three Accounts Payables figures came in at $2.5 million (Q1 2026), $2.5 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 2.49 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | 5.76 Mn |
| Mar 31, 2025 | 5.38 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Sep 30, 2024 | 5.07 Mn |
| Jun 30, 2024 | 6.90 Mn |
| Mar 31, 2024 | 6.57 Mn |
| Dec 31, 2023 | 5.91 Mn |
| Sep 30, 2023 | 5.36 Mn |
| Jun 30, 2023 | 5.34 Mn |
| Mar 31, 2023 | 4.97 Mn |
| Dec 31, 2022 | 6.88 Mn |
| Sep 30, 2022 | 5.87 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Mar 31, 2022 | 4.41 Mn |
| Dec 31, 2021 | 3.86 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 2.34 Mn |